BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15225829)

  • 21. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV; Yang J; Fernandez E; Dusso A
    Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in expression of transforming growth factor-alpha and epidermal growth factor receptor mRNA in Waved-1 and C57Bl6 mice.
    Koshibu K; Levitt P
    Neuroscience; 2005; 134(3):877-87. PubMed ID: 15994019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D physiology.
    Lips P
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal failure and vitamin D].
    Brown AJ; Dusso AS; Slatopolsky E
    Clin Calcium; 2002 Jun; 12(6):711-23. PubMed ID: 15775356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D receptor and analogs.
    Dusso AS; Thadhani R; Slatopolsky E
    Semin Nephrol; 2004 Jan; 24(1):10-6. PubMed ID: 14730505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
    Cañadillas S; Canalejo A; Santamaría R; Rodríguez ME; Estepa JC; Martín-Malo A; Bravo J; Ramos B; Aguilera-Tejero E; Rodríguez M; Almadén Y
    J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced TGFalpha-EGFR expression and P53 gene alterations contributes to gastric tumors aggressiveness.
    Espinoza LA; Tone LG; Neto JB; Costa RS; Wang QJ; Ballejo G
    Cancer Lett; 2004 Aug; 212(1):33-41. PubMed ID: 15246559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New insights in the pathogenesis of secondary hyperparathyroidism].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Bellasi A; Galassi A; Gallieni M; Brancaccio D
    G Ital Nefrol; 2005; 22(4):329-36. PubMed ID: 16267793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
    Amann J; Kalyankrishna S; Massion PP; Ohm JE; Girard L; Shigematsu H; Peyton M; Juroske D; Huang Y; Stuart Salmon J; Kim YH; Pollack JR; Yanagisawa K; Gazdar A; Minna JD; Kurie JM; Carbone DP
    Cancer Res; 2005 Jan; 65(1):226-35. PubMed ID: 15665299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid glands in calcium regulation and human disease.
    Akerström G; Hellman P; Hessman O; Segersten U; Westin G
    Ann N Y Acad Sci; 2005 Apr; 1040():53-8. PubMed ID: 15891005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two modes of ERK activation by TNF in keratinocytes: different cellular outcomes and bi-directional modulation by vitamin D.
    Ziv E; Rotem C; Miodovnik M; Ravid A; Koren R
    J Cell Biochem; 2008 May; 104(2):606-19. PubMed ID: 18080320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
    Stevenson D; Charalambous C; Wilson JB
    Cancer Res; 2005 Oct; 65(19):8826-35. PubMed ID: 16204053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen.
    Takeyama K; Tamaoki J; Kondo M; Isono K; Nagai A
    Clin Exp Allergy; 2008 May; 38(5):857-65. PubMed ID: 18307528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
    Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Imazeki I; Kusano E; Shigematsu T; Akizawa T
    Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.